|
|
|
|
|
by joezydeco
3019 days ago
|
|
I honestly believe Holmes, as a sophomore at Stanford University, believed she had come across an idea that nobody had ever thought of before (low-volume microfluidic immunoassays). The exception is that this science had already been explored, for decades, by the major companies that specialized in this technology. There simply was nothing to show that worked, yet, so there was nothing to commercialize. And the big players aren't going to publish their interim research, or Holmes wasn't motivated to actually do the homework. She wasn't the first to think of it, but had enough traction (combined with a vaccuum of commercial products) to convince people she had, or had some mystery secret sauce that was going to make it work. The fact that Theranos hired Cass Grandone, an Abbott Diagnostics exec that pioneered the previous generation of microparticle immunoassay/ELISA technology, and Grandone walked away after six months shows that he knew their science never worked, and was never going to work. |
|